dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Maisterra Santos, Olga |
dc.contributor.author | Jimenez Balado, Joan |
dc.contributor.author | Carrera, Caty |
dc.contributor.author | Torres‑Aguila, Nuria P. |
dc.contributor.author | Muiño, Elena |
dc.contributor.author | Cullell, Natalia |
dc.date.accessioned | 2021-11-15T11:45:03Z |
dc.date.available | 2021-11-15T11:45:03Z |
dc.date.issued | 2021-03-25 |
dc.identifier.citation | Muiño E, Maisterra O, Jiménez-Balado J, Cullell N, Carrera C, Torres-Aguila NP, et al. Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment. Sci Rep. 2021 Mar 25;11:6846. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/6545 |
dc.description | Demència; Mal de cap; Ictus |
dc.description.sponsorship | This work was supported by a grant from the Carlos III Health Institute (PI 11/0176), Generación Project, Maestro Project, INVICTUS + network, Epigenesis Project (Marató de TV3), FEDER funds and economic donations from “Asociación CADASIL España”. E. Muiño is supported by a Río Hortega Contract (CM18/00198) from the Carlos III Health Institute. J. Cárcel-Márquez is supported by an AGAUR Contract (agència de gestió d'ajuts universitaris i de recerca; FI_DGR 2019, grant number 2019_FI_B 00853) co-financed with Fons Social Europeu (FSE). M. Lledós is supported by a PFIS Contract (Contratos Predoctorales de Formación en Investigación en Salud) from the Carlos III Health Institute. |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Scientific Reports;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Trastorns de la cognició |
dc.subject | Transcriptomes |
dc.subject.mesh | Transcriptome |
dc.subject.mesh | Cognitive Dysfunction |
dc.subject.mesh | /pathology |
dc.title | Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-021-86349-1 |
dc.subject.decs | transcriptoma |
dc.subject.decs | disfunción cognitiva |
dc.subject.decs | /patología |
dc.relation.publishversion | https://doi.org/10.1038/s41598-021-86349-1 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Muiño E, Carrera C, Torres-Aguila NP] Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Maisterra O, Jiménez-Balado J] Laboratori de Recerca Neurovascular, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Cullell N] Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l`Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Stroke Pharmacogenomics and Genetics, Fundació MútuaTerrassa per la Docència i la Recerca, Terrassa, Spain |
dc.identifier.pmid | 33767277 |
dc.identifier.wos | 000635699600007 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CM18%2F00198 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |